Se emiten menos recetas de opioides en EE.UU.
JUEVES, 11 de agosto de 2022 (HealthDay News) — En Estados Unidos hay una epidemia de opioides, pero hay una buena noticia en la lucha contra esta epidemia: los pacientes con un seguro privado están recibiendo menos recetas de estos adictivos fármaco…
Learn MoreDirect-to-Consumer Advertising Has Positive Impact on Rx Demand
FRIDAY, Aug. 12, 2022 (HealthDay News) — Brief exposure to direct-to-consumer advertising (DTCA) has a large and positive association with medication-related demand intentions, according to a study published online Aug. 12 in JAMA Health Forum.
M…
Learn MoreHere’s How New Federal Legislation Might Cut Your Drug Costs
FRIDAY, Aug. 12, 2022 (HealthDay News) — The Inflation Reduction Act is expected to bring out-of-pocket drug costs down for many U.S. seniors, but most of its benefits aren’t immediate.Under the law, Medicare will now be allowed to negotiate the cost…
Learn MoreSurvival Benefit Seen With Triple Therapy for Severe COVID-19
THURSDAY, Aug. 11, 2022 (HealthDay News) — For patients with severe COVID-19 requiring high flow nasal cannula (HFNC), triple therapy of dexamethasone, remdesivir, and baricitinib is associated with significant survival benefit compared with dual t…
Learn MorePolypharmacy Prevalent Among Older Adults With Blood Cancers
THURSDAY, Aug. 11, 2022 (HealthDay News) — For older adults with blood cancers, taking eight or more medications is associated with frailty, according to a study published in the August issue of the Journal of the National Comprehensive Cancer Netw…
Learn MoreU.S. Opioid Prescriptions Are Declining
THURSDAY, Aug. 11, 2022 (HealthDay News) — The United States has an opioid epidemic, but there’s one bright spot in the fight against it: Prescriptions for these addictive drugs have declined for patients with private insurance.Amid guidelines over t…
Learn MoreFew Insured Individuals Receive Timely DAA Treatment for Hep C
WEDNESDAY, Aug. 10, 2022 (HealthDay News) — Few insured individuals with hepatitis C virus (HCV) infection receive timely direct-acting antiviral (DAA) treatment, according to research published in the Aug. 9 early-release issue of the U.S. Center…
Learn MoreUse of Medication Therapy for Opioid Use Disorder Increased 2010 to 2019
WEDNESDAY, Aug. 10, 2022 (HealthDay News) — Despite some progress in expanding access to medications to treat opioid use disorder (MOUD), a substantial gap between OUD prevalence and treatment receipt still exists, according to a study published onli…
Learn MoreFDA Approves First Targeted Therapy for HER2-Low Breast Cancer
MONDAY, Aug. 8, 2022 (HealthDay News) — The U.S. Food and Drug Administration has approved Enhertu (am-trastuzumab-deruxtecan-nxki), an intravenous infusion treatment for patients with unresectable or metastatic human epidermal growth factor receptor…
Learn MoreMonoclonal Antibodies No Better Than Placebo for Early Parkinson Disease
THURSDAY, Aug. 4, 2022 (HealthDay News) — The monoclonal antibodies cinpanemab and prasinezumab show almost no benefit for early Parkinson disease, according to two phase 2 trials published in the Aug. 4 issue of the New England Journal of Medicine…
Learn More